XML 29 R19.htm IDEA: XBRL DOCUMENT v3.10.0.1
JOINT VENTURE FOR DEVELOPMENT OF APO E MIMETIC PEPTIDE MOLECULE AEM-28 AND ANALOGS (Details Textual) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended 74 Months Ended
Aug. 11, 2017
Aug. 03, 2012
Apr. 30, 2018
Oct. 27, 2017
Aug. 31, 2017
Aug. 25, 2016
Jun. 01, 2016
Mar. 31, 2016
Sep. 30, 2017
Sep. 30, 2018
Dec. 31, 2016
Sep. 30, 2018
Mar. 31, 2018
Dec. 31, 2017
Jul. 14, 2017
Mar. 31, 2017
Related Party Transaction [Line Items]                                
Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures   $ 6,000,000               $ 6,000,000   $ 6,000,000     $ 287,000  
Joint Venture Investments In Voting Common Ownership Units (in shares)   600,000                            
Joint Venture Investments In Non Voting Preferred Ownership Units   5,000,000                            
Development Activities Monthly Fee   $ 63,000                            
Joint Venture, Operating Expenses, Inter Company Transactions                   381,000   9,269,000        
Joint Venture, Operating Expenses Allocated To Company                   381,000   7,658,000        
Percentage Of Non Royalty Income 5.00%                              
Conversion of Stock, Shares Converted 3,500,000             1,500,000                
Conversion of Stock, Shares Issued               120,000                
Joint Venture Method Investment Ownership Percentage   60.00%                            
Class of Warrant or Right, Number of Securities Called by Warrants or Rights           33,088                    
Class of Warrant or Right, Exercise Price of Warrants or Rights           $ 10.70                    
Management Fees             $ 80,000                  
Professional Fees             $ 10,000                  
Accrued Professional Fees         $ 20,000                      
Conversion of Stock, Amount Converted $ 3,500,000                              
Conversion of Stock, Amount Issued $ 1,000,000                              
Interest Payable                   177,000   177,000   $ 68,000    
Other Assets, Current                   $ 68,000   68,000   $ 98,000    
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant   83,480                            
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage                   50.00%            
Payment for Management Fee     $ 50,000                          
Common Stock [Member]                                
Related Party Transaction [Line Items]                                
Joint Venture Losses Recognition Criteria, Common Ownership Equity                   $ 0   $ 0        
Preferred Stock [Member]                                
Related Party Transaction [Line Items]                                
Noncontrolling Interest, Ownership Percentage by Parent                   100.00%   100.00%        
Noncontrolling Interest [Member]                                
Related Party Transaction [Line Items]                                
Noncontrolling interests                       $ 667,000        
Exclusive License Agreement [Member]                                
Related Party Transaction [Line Items]                                
Percentage Of Royalty Payment 3.00%                              
Annual Maintenance Payments $ 25,000                              
Maximum [Member]                                
Related Party Transaction [Line Items]                                
Joint Venture Method Investment Ownership Percentage               64.00%                
Maximum [Member] | Exclusive License Agreement [Member]                                
Related Party Transaction [Line Items]                                
Milestone Payments 500,000                              
Royalty Expense 1,000,000                              
Minimum [Member]                                
Related Party Transaction [Line Items]                                
Joint Venture Method Investment Ownership Percentage               60.00%                
Minimum [Member] | Exclusive License Agreement [Member]                                
Related Party Transaction [Line Items]                                
Milestone Payments 50,000                              
Royalty Expense 500,000                              
Lipimetix [Member]                                
Related Party Transaction [Line Items]                                
Joint Venture Investments Common Ownership Units, Co-venture (in shares)   400,000                            
Ownership Percentage Co-venture   40.00%                            
Noncontrolling interests                   $ 667,000            
Noncash or Part Noncash Acquisition, Net Nonmonetary Assets Acquired (Liabilities Assumed)   $ 378,000               $ 378,000            
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross                   81,479            
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price                   $ 1.07            
Voting Common Ownership Units [Member]                                
Related Party Transaction [Line Items]                                
Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures   1,000,000                            
Non Voting Preferred Ownership Units [Member]                                
Related Party Transaction [Line Items]                                
Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures   $ 5,000,000                            
MrHolliman [Member]                                
Related Party Transaction [Line Items]                                
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross       14,126                        
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price       $ 10.70                        
Ownership As Converted [Member]                                
Related Party Transaction [Line Items]                                
Joint Venture Method Investment Ownership Percentage                   65.11%            
Ownership As Converted [Member] | Lipimetix [Member]                                
Related Party Transaction [Line Items]                                
Equity Method Investment, Ownership Percentage   69.75%               60.00%   60.00%        
Ownership as converted including options and warrants [Member]                                
Related Party Transaction [Line Items]                                
Joint Venture Method Investment Ownership Percentage       64.31%                        
Series B2 Preferred Stock [Member]                                
Related Party Transaction [Line Items]                                
Joint Venture Losses Recognition Criteria, Common Ownership Equity           $ 946,000                    
Proceeds From Issuance Of Preferred Stock Before Adjusted Stock Issuance Costs           1,012,000                    
Proceeds from Issuance of Preferred Stock and Preference Stock $ 15,000         946,000                    
Stock Issued During Period, Shares, Acquisitions 93,458                              
Stock Issued During Period, Value, Acquisitions $ 1,000,000                              
Series B1 And B2 Preferred Stock [Member]                                
Related Party Transaction [Line Items]                                
Joint Venture Method Investment Ownership Percentage   62.20%                            
Series B1 Preferred Stock [Member]                                
Related Party Transaction [Line Items]                                
Proceeds From Issuance Of Preferred Stock Before Adjusted Stock Issuance Costs           1,012,000                    
Proceeds from Issuance of Preferred Stock and Preference Stock           946,000                    
Payments of Stock Issuance Costs           $ 66,000                    
Stock Issued During Period, Shares, New Issues           94,537                    
Management Fees         $ 300,000           $ 300,000          
Professional Fees                     60,000          
Management Fee Expense                 $ 150,000   $ 250,000          
Other Commitment, Due in Second Year                         $ 150,000      
Accrued Professional Fees                               $ 50,000
Revolving Credit Facility [Member]                                
Related Party Transaction [Line Items]                                
Long-term Line of Credit                   $ 1,700,000   $ 1,700,000        
Interest Payable                   $ 100,000   $ 100,000